Loading insider details...
Beta
Latest Form 4 (Sep 30, 2026): Conversion of 1,300,530 ATER shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Aterian, Inc. (ATER) | Conversion | 1,300,530 | n/a |
| Sep 11, 2026 | Aterian, Inc. (ATER) | Conversion | 875,000 | $1.75M |
| Aug 7, 2026 | Quantum Cyber N.V. (QUCY) | Conversion | 9,000,000 | $81.00M |
| May 1, 2026 | Aterian, Inc. (ATER) | Grant/Award | 1,750,000 | n/a |
| Apr 28, 2026 | Quantum Cyber N.V. (MYNZ) | Grant/Award | 1,000,000 | $1.50M |
| Apr 2, 2026 | Sow Good Inc. (SOWG) | Grant/Award | 5,740,000 | $819.7K |
| Mar 24, 2026 | Indaptus Therapeutics, Inc. (INDP) | Sale | 196,800 | n/a |
| Mar 3, 2026 | MAINZ BIOMED N.V. (MYNZ) | Grant/Award | 1,000,000 | n/a |
| Jan 30, 2026 | NovaBay Pharmaceuticals, Inc. (NBY) | Grant/Award | 6,388,000 | n/a |
| Jan 6, 2026 | Sow Good Inc. (SOWG) | Grant/Award | 1,500,000 | $3.00M |